Edwards Lifesciences shares are trading lower following Q2 results. The company reported an adjusted gross profit margin of 77.7%, down from 80.5% last year.
Portfolio Pulse from Bill Haddad
Edwards Lifesciences reported a decrease in its adjusted gross profit margin to 77.7% in Q2, down from 80.5% last year, leading to a drop in its share price.
July 27, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Edwards Lifesciences' Q2 results revealed a decrease in its adjusted gross profit margin, which has negatively impacted its share price.
Edwards Lifesciences' Q2 results showed a decrease in its adjusted gross profit margin, which is a key profitability indicator. This decrease suggests that the company's profitability has declined, which is likely to be viewed negatively by investors, leading to a decrease in the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100